Indeed, other studies have shown that, on apoptosis-resistant cancer cells, stimulation of CD95 results in activation of NF-κB and MAP kinases inducing increased motility and invasiveness of cancer, which reflects the function of CD95 as a tumour promotor34. This evidence concerns the gene NFKB1 and cancer.